Globus Medical announced its US$ 250 million acquisition of Nevro on February 6, 2025, gaining control of their large spinal cord stimulation (SCS) patent portfolio. This acquisition expands Globus' neuromodulation patent portfolio and strengthens its position in the US$13.3 billion spinal device market. A market that is